Home Coronavirus COVID-19 Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85%... Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85% Against Severe Disease January 29, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Lake Chapala Activists Urge President Sheinbaum to Halt Third Aqueduct Project U.S. Sanctions CJNG Leaders in Connection with TikTok Influencer’s Murder Mexico-Canada Relations Take Center Stage During Sheinbaum’s G7 Visit Sheinbaum Rejects U.S. Claims of Encouraging Violent Protests Canada Day Celebration Coming to Chapala
